Business Development


Business Development

We believe that advances in therapeutic and laboratory medicine can be accelerated through collaboration.

Exagen offers the following capabilities:

Business Collaborations

  • Autoimmune rheumatic disease pharmaceutical and diagnostic co-promotion
  • Autoimmune disease biomarker licensing
  • Complementary/Companion diagnostic development
  • Collaboration studies with novel Exagen biomarkers

Clinical Laboratory Services

  • Drug-development clinical trial support
  • Test interpretation/clinical consultation
  • Access to biorepository of well-characterized autoimmune rheumatic disease samples
  • Contract laboratory services

If you have an idea for working with Exagen, or a question about current collaborations please contact contact PR line 888.452.1522 or Matthew Brown, Director of Business Development at 760.295.4524.